» Articles » PMID: 16292310

Superspreading and the Effect of Individual Variation on Disease Emergence

Overview
Journal Nature
Specialty Science
Date 2005 Nov 18
PMID 16292310
Citations 1113
Authors
Affiliations
Soon will be listed here.
Abstract

Population-level analyses often use average quantities to describe heterogeneous systems, particularly when variation does not arise from identifiable groups. A prominent example, central to our current understanding of epidemic spread, is the basic reproductive number, R(0), which is defined as the mean number of infections caused by an infected individual in a susceptible population. Population estimates of R(0) can obscure considerable individual variation in infectiousness, as highlighted during the global emergence of severe acute respiratory syndrome (SARS) by numerous 'superspreading events' in which certain individuals infected unusually large numbers of secondary cases. For diseases transmitted by non-sexual direct contacts, such as SARS or smallpox, individual variation is difficult to measure empirically, and thus its importance for outbreak dynamics has been unclear. Here we present an integrated theoretical and statistical analysis of the influence of individual variation in infectiousness on disease emergence. Using contact tracing data from eight directly transmitted diseases, we show that the distribution of individual infectiousness around R(0) is often highly skewed. Model predictions accounting for this variation differ sharply from average-based approaches, with disease extinction more likely and outbreaks rarer but more explosive. Using these models, we explore implications for outbreak control, showing that individual-specific control measures outperform population-wide measures. Moreover, the dramatic improvements achieved through targeted control policies emphasize the need to identify predictive correlates of higher infectiousness. Our findings indicate that superspreading is a normal feature of disease spread, and to frame ongoing discussion we propose a rigorous definition for superspreading events and a method to predict their frequency.

Citing Articles

Unlocking the power of time-since-infection models: data augmentation for improved instantaneous reproduction number estimation.

Shi J, Zhou Y, Huang J Biostatistics. 2025; 26(1).

PMID: 40036311 PMC: 11878408. DOI: 10.1093/biostatistics/kxae054.


Model predicted human mobility explains COVID-19 transmission in urban space without behavioral data.

Han Z, Xu F, Li Y, Jiang T, Evans J Sci Rep. 2025; 15(1):6365.

PMID: 39984518 PMC: 11845774. DOI: 10.1038/s41598-025-87363-3.


Quantifying infectious disease epidemic risks: A practical approach for seasonal pathogens.

Kaye A, Guzzetta G, Tildesley M, Thompson R PLoS Comput Biol. 2025; 21(2):e1012364.

PMID: 39970184 PMC: 11867399. DOI: 10.1371/journal.pcbi.1012364.


Detection of an Alphacoronavirus in a Brazilian Bat (Molossus sp.).

Molina C, Magalhaes M, Rodrigues A, Taniwaki S, de Souza Silva S, Konig G J Mol Evol. 2025; .

PMID: 39961834 DOI: 10.1007/s00239-025-10236-w.


Systematic shifts in the variation among host individuals must be considered in climate-disease theory.

Mihaljevic J, Paez D Proc Biol Sci. 2025; 292(2040):20242515.

PMID: 39904391 PMC: 11793970. DOI: 10.1098/rspb.2024.2515.


References
1.
Lipsitch M, Cohen T, Cooper B, Robins J, Ma S, James L . Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003; 300(5627):1966-70. PMC: 2760158. DOI: 10.1126/science.1086616. View

2.
Wallinga J, Teunis P . Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am J Epidemiol. 2004; 160(6):509-16. PMC: 7110200. DOI: 10.1093/aje/kwh255. View

3.
Koopman J . Modeling infection transmission. Annu Rev Public Health. 2004; 25:303-26. DOI: 10.1146/annurev.publhealth.25.102802.124353. View

4.
Dye C, Gay N . Epidemiology. Modeling the SARS epidemic. Science. 2003; 300(5627):1884-5. DOI: 10.1126/science.1086925. View

5.
Farrington C, Kanaan M, Gay N . Branching process models for surveillance of infectious diseases controlled by mass vaccination. Biostatistics. 2003; 4(2):279-95. DOI: 10.1093/biostatistics/4.2.279. View